Regulation of vascular smooth muscle cell autophagy by DNA nanotube-conjugated mTOR siRNA.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 26210180.
- Also identified by DOI 10.1016/j.biomaterials.2015.07.015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The efficient delivery of short interfering RNA (siRNA) is an enormous challenge in the field of gene therapy. Herein, we report a delivery nanosystem based on programmed DNA self-assembly mammalian target of rapamycin (mTOR) siRNA-loaded DNA nanotubes (DNA-NTs). We demonstrate that these siRNA-DNA-NTs can be effectively transfected into pulmonary arterial smooth muscle cells (PASMCs) via endocytosis; and that the loaded mTOR siRNA can induce obvious autophagy and inhibit cell growth under both normal and hypoxic conditions. Moreover, we found that mTOR siRNA can control the autophagy and proliferation of PASMCs under hypoxic condition, suggesting a potential therapeutic application for mTOR siRNA in diseases involving abnormal autophagy in PASMCs.
Medical subject headings
- Autophagy
- DNA
- Muscle, Smooth, Vascular
- Myocytes, Smooth Muscle
- Nanotubes
- RNA, Small Interfering
- TOR Serine-Threonine Kinases